HUMAW
Income statement / Annual
Last year (2024), Humacyte, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Humacyte, Inc.'s net income was -$148.70 M.
See Humacyte, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$1.57 M |
$1.26 M |
$1.49 M |
$6.19 M |
| Cost of Revenue |
$7.19 M
|
$76.55 M
|
$8.26 M
|
$61.34 M
|
$54.08 M
|
$75.60 M
|
| Gross Profit |
-$7.19 M
|
-$76.55 M
|
-$6.69 M
|
-$60.08 M
|
-$52.59 M
|
-$69.42 M
|
| Gross Profit Ratio |
0
|
0
|
-4.27
|
-47.57
|
-35.27
|
-11.22
|
| Research and Development Expenses |
$88.60 M
|
$76.55 M
|
$63.26 M
|
$61.34 M
|
$54.08 M
|
$75.60 M
|
| General & Administrative Expenses |
$25.80 M
|
$23.39 M
|
$22.88 M
|
$21.03 M
|
$11.86 M
|
$16.28 M
|
| Selling & Marketing Expenses |
$0.00
|
-$3.00 M
|
$0.00
|
$105.00 K
|
$152.00 K
|
$0.00
|
| Selling, General & Administrative Expenses |
$25.80 M
|
$20.39 M
|
$22.88 M
|
$21.13 M
|
$12.01 M
|
$16.28 M
|
| Other Expenses |
-$7.19 M
|
-$73.44 M
|
-$8.26 M
|
-$61.34 M
|
-$54.08 M
|
-$75.60 M
|
| Operating Expenses |
$107.21 M
|
$23.50 M
|
$77.89 M
|
$21.13 M
|
$12.01 M
|
$16.28 M
|
| Cost And Expenses |
$114.40 M
|
$100.05 M
|
$86.14 M
|
$82.47 M
|
$66.09 M
|
$91.88 M
|
| Interest Income |
$4.10 M
|
$5.47 M
|
$2.63 M
|
$16.00 K
|
$278.00 K
|
$269.00 K
|
| Interest Expense |
$9.28 M
|
$6.60 M
|
$6.20 M
|
$4.35 M
|
$2.20 M
|
$2.30 M
|
| Depreciation & Amortization |
$7.19 M
|
$7.72 M
|
$8.21 M
|
$8.24 M
|
$8.35 M
|
$6.75 M
|
| EBITDA |
-$132.23 M |
-$96.46 M |
-$76.37 M |
-$72.97 M |
-$56.25 M |
-$78.94 M |
| EBITDA Ratio |
0
|
0
|
-48.8
|
-57.77
|
-37.73
|
-12.76
|
| Operating Income Ratio |
0
|
0
|
-54.04
|
-64.3
|
-43.33
|
-13.85
|
| Total Other Income/Expenses Net |
-$34.30 M
|
-$10.73 M
|
$72.61 M
|
$54.73 M
|
-$1.92 M
|
$269.00 K
|
| Income Before Tax |
-$148.70 M
|
-$110.78 M
|
-$11.97 M
|
-$26.48 M
|
-$66.52 M
|
-$85.42 M
|
| Income Before Tax Ratio |
0
|
0
|
-7.65
|
-20.96
|
-44.62
|
-13.81
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$148.70 M
|
-$110.78 M
|
-$11.97 M
|
-$26.48 M
|
-$66.52 M
|
-$85.42 M
|
| Net Income Ratio |
0
|
0
|
-7.65
|
-20.96
|
-44.62
|
-13.81
|
| EPS |
-1.26 |
-1.07 |
-0.12 |
-0.66 |
-5.52 |
-4.25 |
| EPS Diluted |
-1.26 |
-1.07 |
-0.12 |
-0.66 |
-5.52 |
-4.25 |
| Weighted Average Shares Out |
$118.48 M
|
$103.42 M
|
$103.05 M
|
$39.97 M
|
$12.45 M
|
$20.12 M
|
| Weighted Average Shares Out Diluted |
$118.48 M
|
$103.42 M
|
$103.05 M
|
$39.97 M
|
$12.45 M
|
$20.12 M
|
| Link |
|
|
|
|
|
|
